Prestige Consumer Healthcare Inc. (PBH) Social Stream
PRESTIGE CONSUMER HEALTHCARE INC (PBH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRESTIGE CONSUMER HEALTHCARE INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-05 | 4 | $65 | $61 | $63 | $56.7 | 11.11% |
2022-02-07 | 4 | $65 | $63 | $64 | $56.7 | 12.87% |
2022-05-09 | 4 | $65 | $60 | $62.5 | $56.7 | 10.23% |
2022-08-04 | 4 | $70 | $60 | $64.333 | $56.7 | 13.46% |
2022-08-09 | 5 | $112 | $60 | $77.5 | $56.7 | 36.68% |
2022-09-27 | 5 | $112 | $60 | $78.333 | $56.7 | 38.15% |
2022-11-07 | 5 | $112 | $60 | $76.25 | $56.7 | 34.48% |
2022-11-17 | 6 | $112 | $60 | $75.2 | $56.7 | 32.63% |
2023-02-06 | 6 | $112 | $60 | $77 | $56.7 | 35.8% |
2023-05-08 | 6 | $112 | $60 | $76.8 | $56.7 | 35.45% |
The Trend in the Analyst Price Target
PBH's average price target has moved up $14.07 over the prior 40 weeks.
PBH reports an average of 29.89% for its upside potential over the past 46 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-08-04 | 4 | 70 | 60 | 64.333 | 58.97 | 9.09% |
2023-01-13 | 6 | 112 | 60 | 77.000 | 66.62 | 15.58% |
2023-02-06 | 6 | 112 | 60 | 77.000 | 60.82 | 26.6% |
2023-05-08 | 6 | 112 | 60 | 76.800 | 59.50 | 29.08% |
2023-05-08 | 6 | 112 | 60 | 78.400 | 59.50 | 31.76% |
PBH Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.67 | 4 | 0 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 52 weeks, PBH's average broker recommendation rating worsened by 0.17.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PRESTIGE CONSUMER HEALTHCARE INC's variance in analysts' estimates is lower than -466.16% of all US stocks.
- In the context of all US stocks, PRESTIGE CONSUMER HEALTHCARE INC's number of analysts covering the stock is higher than 282.83% of them.
- PBH has a greater upside potential (average analyst target price relative to current price) than 261.14% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PRESTIGE CONSUMER HEALTHCARE INC's average analyst price target is greater than 1028.44% of them.
In the Pharmaceutical Products industry, ICPT, FOLD, and CORT are the three stocks most similar to PRESTIGE CONSUMER HEALTHCARE INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PBH? Use POWR Ratings for clearer insight into price direction.